Veterinary Infectious Disease Diagnostics Market by Technology (Immunodiagnostics, Molecular Diagnostics (PCR)), Animal (Companion, Food-producing animals), End User (Reference Labs, Hospital, Clinics, Universities) - Global Forecast to 2026
Veterinary infectious disease diagnostics market forecasted to transform from $1.7 billion in 2021 to $2.6 billion by 2026, driven by a CAGR of 9.0%. The research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
Growth can largely be attributed to the growth in the companion animal population, increasing incidence of transboundary and zoonotic diseases, rising demand for animal-derived food products, rising demand for pet insurance, growing animal health expenditure, and growth in the number of veterinary practitioners and income levels in developed economies. On the other hand, rising petcare costs is expected to restrain the overall market growth. Currently, the lack of skilled veterinarians and diagnostic infrastructure, especially in developing countries, is one of the major factors limiting the uptake of advanced diagnostic solutions among veterinarians. The high cost of advanced diagnostic tests is another major barrier to its widespread adoption.
To know about the assumptions considered for the study, Request for Free Sample Report
Veterinary Infectious Disease Diagnostics Market Dynamics
Driver: Growth in the companion animal population
A surge in the overall companion animal population and adoption rate has been witnessed on a global scale. According to several studies, having a companion animal is associated with positive health benefits, such as reduced cardiac arrhythmias, normalization of blood pressure, decreased anxiety, greater psychological stability, and improved well-being. The increasing pet population is expected to drive the demand for pet care products and services, which, in turn, will support the growth of dependent industries such as veterinary infectious disease diagnostics.
North America:
- According to a National Pet Owners Survey (2019–2020) conducted by the American Pet Products Association (APPA), an estimated 67% of US households, or about 84.9 million families, owned a pet.
- Around 63.4 million households owned dogs, 42.7 million owned cats, and 1.6 million owned horses in the US in 2018.
Restraint: Rising pet care costs
The pet insurance market is expanding, the number of animals covered for treatments is still very low. As a result, animal owners generally bear the majority of the cost of treatments. In addition, according to the Society for Practicing Veterinary Surgeons, along with the increasing pet insurance, the cost of veterinary treatment is rising at a significant growth rate.
The number of consultations with veterinary specialists for pet care is another factor responsible for the increasing pet healthcare costs. Furthermore, the lower income in this profession compared to other advanced-degree professions such as dentistry and law puts pressure on veterinary professionals to increase their fees. High pet care costs directly impact the number of visits by pet owners to veterinary facilities, thereby restraining the growth of this market.
Opportunity: Increased use of PCR testing panels to rule out COVID-19 virus in animals
With regard to the current COVID-19 pandemic, animal health authorities have been carrying out tests to understand how the virus is affecting animals. So far, research studies and testing show that felines are more susceptible than other animals. Testing also shows that the virus spreads less from animal to animal as opposed to human-human or human-animal. It is expected that pet owners will increasingly start testing their pets for the absence of these diseases, thus increasing the demand for PCR panels for virus testing. This will create opportunities for new molecular diagnostics panels in the industry.
Challenge: Shortage of veterinary practitioners in developing markets
The global animal healthcare industry is marked by a shortage of skilled veterinarians and pathologists. This is particularly evident in the emerging markets across countries like Brazil, China, and Southeast Asian countries, which show a huge gap in the demand and supply of veterinary professionals. Shortages are observed in developing countries such as. The majority of veterinarians across the globe work in private practices dedicated to companion animals, which leads to a shortage of resources for farm animals or food-producing animals.
Currently, the lack of skilled veterinarians and diagnostic infrastructure, especially in developing countries, is one of the major factors limiting the uptake of advanced diagnostic solutions among veterinarians. The high cost of advanced diagnostic tests is another major barrier to its widespread adoption.
North America is expected to account for the largest share of the veterinary infectious disease diagnostics market in 2020
In 2020, North America accounted for the largest share of the global veterinary infectious disease diagnostics market. The growth in the veterinary diagnostics market of North America is characterized by the increasing population of companion and food-producing animals, rising meat and dairy product consumption, the availability of technologically advanced veterinary reference laboratories, rising veterinary healthcare expenditure, and growth in pet insurance coverage.
To know about the assumptions considered for the study, download the pdf brochure
Some of the major players in the veterinary infectious disease diagnostics market include IDEXX Laboratories, Inc. (US), Zoetis, Inc. (US), Thermo Fisher Scientific, Inc. (US), Virbac (France), bioMérieux SA (France), Heska Corporation (US), IDvet (France), NEOGEN Corporation (US), QIAGEN N.V. (a part of INDICAL Bioscience) (Europe), Randox Laboratories Ltd. (UK), Agrolabo S.p.A. (Italy), Bio-Rad Laboratories (US), Bionote, Inc. (South Korea), Biogal Galed Labs (Israel), BioChek (Netherlands), (UK), Biopanda Reagents (UK), URIT Medical Electronic Co. Ltd. (China), MEGACOR Diagnostik GmbH (Austria), LIVET (UK), INDICAL BIOSCIENCE GmbH (Germany), Fassisi GmbH (Germany), Alvedia (France), SKYER, Inc. (South Korea), Shenzhen Bioeasy Biotechnology Co., Ltd. (China), and Precision Biosensor (US).
Scope of the Veterinary Infectious Disease Diagnostics Industry
|
Report Metric |
Details |
|
Market Revenue Size in 2021 |
$1.7 billion |
|
Projected Revenue Size by 2026 |
$2.6 billion |
|
Industry Growth Rate |
Poised to Grow at a CAGR of 9.0% |
|
Market Driver |
Growth in the companion animal population |
|
Market Opportunity |
Increased use of PCR testing panels to rule out COVID-19 virus in animals |
The study categorizes the veterinary infectious disease diagnostics market to forecast revenue and analyze trends in each of the following submarkets:
By Technology
-
Immunodiagnostics
- Lateral Flow Assays
- ELISA Test
- Other Immunodiagnostics Products
-
Molecular Diagnostic
- Polymerase Chain Reaction (PCR) Tests
- Microarrays
- Other Molecular Diagnostic Products
- Other Technologies
By Animal Type
-
Companion Animals
- Cats
- Dogs
- Horses
- Other Companion Animals
-
Companion Animals, By Infection Type
- Viral Infections
- Bacterial Infections
- Parasitic Infections
- Other Infections
-
Food-producing Animals
- Cattle
- Pigs
- Poultry
- Other Food-producing animals
-
Food-producing Animals, By Infection Type
- Viral Infections
- Bacterial Infections
- Parasitic Infections
- Other Infections
By End User
- Reference Laboratories
- Veterinary Hospitals and Clinics
- Point-of-care/ In-house testing
- Research Institutes and Universities
By Region
-
North America
- US
- Canada
-
Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
-
Asia Pacific
- China
- India
- Japan
- Rest of APAC
-
Latin America
- Brazil
- Mexico
- Rest of Latin America
- ;Middle East & Africa
Recent Developments
- In April 2021, INDICAL BIOSCIENCE GmbH (Germany) acquired Boehringer Ingelheim’s Svanova product portfolio which helped INDICAL widen its portfolio by adding 25 assays for livestock.
- In April 2021, BioChek (Netherlands) opened a new office in Johannesburg, South Africa.
- In January 2021, Heska Corporation (US) acquired Lacuna Diagnostics (US), this acquisition strengthened the company’s portfolio of point-of-care digital cytology technology and telemedicine services.
- In December 2020, NEOGEN Corporation (US) launched a preventative care DNA screening tool for detecting genetic diseases in dogs.
- In November 2020, NEOGEN Corporation (US) collaborated with Transnetyx Inc. (US), this partnership helped NEOGEN to increase its presence in the animal genomics and diagnostics market.
Frequently Asked Questions (FAQs):
What is the size of Veterinary Infectious Disease Diagnostics Market ?
The global Veterinary Infectious Disease Diagnostics Market is projected to reach USD 2.6 billion by 2026, growing at a CAGR of 9.0%
What are the major growth factors of Veterinary Infectious Disease Diagnostics Market ?
Growth can largely be attributed to the growth in the companion animal population, increasing incidence of transboundary and zoonotic diseases, rising demand for animal-derived food products, rising demand for pet insurance, growing animal health expenditure, and growth in the number of veterinary practitioners and income levels in developed economies. On the other hand, rising petcare costs is expected to restrain the overall market growth.
Who all are the prominent players of Veterinary Infectious Disease Diagnostics Market ?
Some of the major players in the veterinary infectious disease diagnostics market include IDEXX Laboratories, Inc. (US), Zoetis, Inc. (US), Thermo Fisher Scientific, Inc. (US), Virbac (France), bioMérieux SA (France), Heska Corporation (US), IDvet (France), NEOGEN Corporation (US), QIAGEN N.V. (a part of INDICAL Bioscience) (Europe), Randox Laboratories Ltd. (UK), Agrolabo S.p.A. (Italy), Bio-Rad Laboratories (US), Bionote, Inc. (South Korea), Biogal Galed Labs (Israel), BioChek (Netherlands), (UK), Biopanda Reagents (UK), URIT Medical Electronic Co. Ltd. (China), MEGACOR Diagnostik GmbH (Austria), LIVET (UK), INDICAL BIOSCIENCE GmbH (Germany), Fassisi GmbH (Germany), Alvedia (France), SKYER, Inc. (South Korea), Shenzhen Bioeasy Biotechnology Co., Ltd. (China), and Precision Biosensor (US). .
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 41)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION & SCOPE
1.2.1 INCLUSIONS & EXCLUSIONS
1.2.2 MARKET SEGMENTATION
FIGURE 1 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SEGMENTATION
1.2.3 YEARS CONSIDERED FOR THE STUDY
1.3 CURRENCY
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. - 46)
2.1 RESEARCH DATA
FIGURE 2 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
FIGURE 3 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Insights from primary experts
2.1.2.3 Key industry insights
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE PARTICIPANTS, BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: DEMAND-SIDE PARTICIPANTS, BY END USER, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 7 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION: IDEXX LABORATORIES, INC.
FIGURE 9 SUPPLY-SIDE ANALYSIS OF THE TOP COMPANIES: COMPANION DIAGNOSTICS MARKET (2020)
FIGURE 10 SUPPLY-SIDE ANALYSIS OF THE TOP COMPANIES: FOOD-PRODUCING ANIMALS DIAGNOSTICS MARKET (2020)
FIGURE 11 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS INDUSTRY (2021–2026)
FIGURE 12 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 13 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN & DATA TRIANGULATION
FIGURE 14 MARKET DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ANALYSIS
2.5 ASSUMPTIONS FOR THE STUDY
2.6 LIMITATIONS
2.7 RISK ASSESSMENT
TABLE 2 RISK ASSESSMENT: MARKET
3 EXECUTIVE SUMMARY (Page No. - 60)
FIGURE 15 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021 VS. 2026 (USD MILLION)
FIGURE 16 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS INDUSTRY, BY ANIMAL TYPE, 2021 VS. 2026 (USD MILLION)
FIGURE 17 MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
FIGURE 18 GEOGRAPHICAL SNAPSHOT OF THE MARKET
4 PREMIUM INSIGHTS (Page No. - 64)
4.1 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET OVERVIEW
FIGURE 19 GROWING PREVALENCE OF ZOONOTIC DISEASES TO DRIVE THE MARKET GROWTH
4.2 ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS INDUSTRY, BY END USER AND COUNTRY (2020)
FIGURE 20 THE VETERINARY REFERENCE LABORATORIES SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE APAC MARKET IN 2020
4.3 MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 21 ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH IN THE GLOBAL MARKET DURING THE FORECAST PERIOD
4.4 MARKET, BY REGION (2019–2026)
FIGURE 22 NORTH AMERICA WILL CONTINUE TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
4.5 MARKET: DEVELOPED VS. DEVELOPING MARKETS
FIGURE 23 DEVELOPING MARKETS TO REGISTER A HIGHER GROWTH RATE DURING THE FORECAST PERIOD
5 MARKET OVERVIEW (Page No. - 68)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 24 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 MARKET DRIVERS
5.2.1.1 Rising demand for animal-derived food products
TABLE 3 PAST AND PROJECTED TRENDS IN THE CONSUMPTION OF MEAT & MILK IN DEVELOPED AND DEVELOPING COUNTRIES
TABLE 4 ASIA: COUNTRY-LEVEL CONSUMPTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2020 VS. 2030 (THOUSAND METRIC TONS)
FIGURE 25 ASIA WAS THE HIGHEST CONSUMER OF MEAT AND MILK IN 2018
5.2.1.2 Increasing companion animal population
5.2.1.3 Rising demand for pet insurance and the subsequent growth in animal health expenditure
TABLE 5 AVERAGE PREMIUMS PAID IN THE US, 2019 VS. 2020
FIGURE 26 US: PET INDUSTRY EXPENDITURE, 2010–2019
5.2.1.4 Growing number of veterinary practitioners in developed economies
TABLE 6 NUMBER OF VETERINARIANS AND PARAVETERINARIANS IN DEVELOPED COUNTRIES, 2012–2018
5.2.1.5 Increasing disease control & disease prevention measures
5.2.1.6 Rising incidence of transboundary & zoonotic diseases
TABLE 7 ANIMAL DISEASE OUTBREAKS IN ASIA PACIFIC COUNTRIES (2009–2019)
5.2.1.7 Growing demand for advanced diagnostic devices
5.2.2 MARKET RESTRAINTS
5.2.2.1 Rising pet care costs
5.2.2.2 High costs of veterinary diagnostic tests
5.2.3 MARKET OPPORTUNITIES
5.2.3.1 Increasing use of PCR-testing panels for COVID-19 testing in animals
5.2.3.2 Untapped emerging economies
5.2.4 MARKET CHALLENGES
5.2.4.1 Shortage of veterinary practitioners in developing markets
5.2.4.2 Lack of animal healthcare awareness in emerging countries
TABLE 8 NUMBER OF VETERINARY PROFESSIONALS, BY COUNTRY, 2005 VS. 2014 VS. 2018
5.3 IMPACT OF COVID-19 ON THE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS INDUSTRY
TABLE 9 GLOBAL SNAPSHOT OF THE REPORTED CASES OF NATURALLY ACQUIRED SARS- COV-2 (COVID-19) INFECTIONS IN ANIMALS
FIGURE 27 MONTHLY VETERINARY PRACTICE ACTIVITY, BY REGION, JANUARY–JUNE 2020
5.4 INDUSTRY TRENDS
5.4.1 RISING VEGAN POPULATION
5.4.2 ADOPTION OF WEB MONITORING AND OTHER DIGITAL AIDS TO DETECT EMERGING INFECTIOUS DISEASES IN ANIMALS
5.4.3 EXPANSIVE GROWTH IN VETERINARY BUSINESSES
5.5 VALUE CHAIN ANALYSIS
FIGURE 28 MARKET: VALUE CHAIN ANALYSIS
5.6 ECOSYSTEM MARKET MAP
FIGURE 29 MARKET: ECOSYSTEM PARTICIPANTS
FIGURE 30 MARKET: ECOSYSTEM MARKET
5.7 PORTER’S FIVE FORCES ANALYSIS
TABLE 10 MARKET: PORTER’S FIVE FORCES ANALYSIS
5.7.1 THREAT OF NEW ENTRANTS
5.7.2 THREAT OF SUBSTITUTES
5.7.3 BARGAINING POWER OF SUPPLIERS
5.7.4 BARGAINING POWER OF BUYERS
5.7.5 INTENSITY OF COMPETITIVE RIVALRY
5.8 PRICING ANALYSIS
TABLE 11 REGIONAL PRICING ANALYSIS OF VETERINARY ANALYZERS, 2021 (USD)
5.9 PATENT ANALYSIS
5.9.1 PATENT PUBLICATION TRENDS FOR VETERINARY DIAGNOSTICS
5.9.2 PATENT PUBLICATION TRENDS (2011–DECEMBER 2021)
5.9.3 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
FIGURE 31 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR VETERINARY INFECTIOUS DISEASE DIAGNOSTIC PATENTS (JANUARY 2011–DECEMBER 2021)
FIGURE 32 TOP APPLICANT COUNTRIES/REGIONS FOR VETERINARY INFECTIOUS DISEASE DIAGNOSTICS PATENTS (JANUARY 2011–DECEMBER 2021)
5.10 TECHNOLOGICAL ANALYSIS
5.10.1 KEY TECHNOLOGY
5.10.1.1 Development of portable instruments for POC diagnostic services
TABLE 12 PONT-OF-CARE PORTABLE VETERINARY DIAGNOSTIC INSTRUMENTS
5.10.2 ADJACENT TECHNOLOGY
5.10.2.1 Development of rapid and sensitive veterinary diagnostic kits
6 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY (Page No. - 92)
6.1 INTRODUCTION
TABLE 13 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS INDUSTRY, BY TECHNOLOGY, 2019–2026 (USD MILLION)
6.2 IMMUNODIAGNOSTICS
TABLE 14 KEY VETERINARY IMMUNODIAGNOSTIC PRODUCTS AVAILABLE IN THE MARKET
TABLE 15 MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 16 MARKET FOR IMMUNODIAGNOSTICS, BY COUNTRY, 2019–2026 (USD MILLION)
6.2.1 LATERAL FLOW ASSAYS
6.2.1.1 Lateral flow assays offer rapid results & accurate diagnosis
TABLE 17 LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
6.2.2 ELISA TESTS
6.2.2.1 ELISA tests have gained widespread popularity in the market owing to their efficacy and accurate validation of results
TABLE 18 ELISA TESTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
6.2.3 OTHER IMMUNODIAGNOSTIC PRODUCTS
TABLE 19 OTHER IMMUNODIAGNOSTIC PRODUCTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
6.3 MOLECULAR DIAGNOSTICS
TABLE 20 KEY VETERINARY MOLECULAR DIAGNOSTICS PRODUCTS AVAILABLE IN THE MARKET
TABLE 21 MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 22 MARKET FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2019–2026 (USD MILLION)
6.3.1 POLYMERASE CHAIN REACTION (PCR) TESTS
6.3.1.1 PCR is an effective tool for the diagnosis of diseases in food-producing animals and companion animals
TABLE 23 PCR TESTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
6.3.2 MICROARRAYS
6.3.2.1 Technological advancements and the increasing incidence of infectious diseases are factors supporting the growth of this market
TABLE 24 MICROARRAYS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
6.3.3 OTHER MOLECULAR DIAGNOSTIC PRODUCTS
TABLE 25 OTHER MOLECULAR DIAGNOSTIC PRODUCTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
6.4 OTHER TECHNOLOGIES
TABLE 26 MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2019–2026 (USD MILLION)
7 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE (Page No. - 106)
7.1 INTRODUCTION
TABLE 27 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS INDUSTRY, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
7.2 COMPANION ANIMALS
TABLE 28 POPULATION OF COMPANION ANIMALS, BY COUNTRY, 2012–2019 (MILLION)
TABLE 29 INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 30 INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.1 DOGS
7.2.1.1 The pet dog population has grown significantly in recent years
TABLE 31 SOME OF THE MAJOR ZOONOTIC DISEASES AFFECTING DOGS
TABLE 32 SOME OF THE MAJOR INFECTIOUS DISEASES AFFECTING DOGS
TABLE 33 MARKET FOR DOGS, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.2 CATS
7.2.2.1 Increasing pet cat population to drive the market growth
TABLE 34 SOME OF THE MAJOR ZOONOTIC DISEASES AFFECTING CATS
TABLE 35 SOME OF THE MAJOR INFECTIOUS DISEASES AFFECTING CATS
TABLE 36 MARKET FOR CATS, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.3 HORSES
7.2.3.1 Research programs on horse health awareness is a major factor driving the demand for infection diagnostics for this segment
TABLE 37 HORSE POPULATION, BY REGION, 2014–2017 (USD MILLION)
TABLE 38 SOME OF THE MAJOR ZOONOTIC DISEASES AFFECTING HORSES
TABLE 39 SOME OF THE MAJOR INFECTIOUS DISEASES AFFECTING HORSES
TABLE 40 MARKET FOR HORSES, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.4 OTHER COMPANION ANIMALS
TABLE 41 MARKET FOR OTHER COMPANION ANIMALS, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.5 INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY INFECTION TYPE
TABLE 42 INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)
7.2.5.1 Viral infections
7.2.5.1.1 The highly contagious nature of viral diseases is a major factor driving the demand for infection diagnostics in companion animals
TABLE 43 PRODUCTS OFFERED FOR THE DIAGNOSIS OF VIRAL INFECTIONS IN COMPANION ANIMALS
TABLE 44 VIRAL DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY REGION, 2019–2026 (USD MILLION)
7.2.5.2 Bacterial infections
7.2.5.2.1 The bacterial infections segment accounted for the largest share of the market in 2020
TABLE 45 PRODUCTS OFFERED FOR THE DIAGNOSIS OF BACTERIAL INFECTIONS IN COMPANION ANIMALS
TABLE 46 BACTERIAL DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY REGION, 2019–2026 (USD MILLION)
7.2.5.3 Parasitic infections
7.2.5.3.1 Rising incidence of worm infestation in companion animals to support the growth of this market
TABLE 47 PRODUCTS OFFERED FOR THE DIAGNOSIS OF PARASITIC INFECTIONS IN COMPANION ANIMALS
TABLE 48 PARASITIC DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY REGION, 2019–2026 (USD MILLION)
7.2.5.4 Other infections
TABLE 49 PRODUCTS OFFERED FOR THE DIAGNOSIS OF FUNGAL INFECTIONS IN COMPANION ANIMALS
TABLE 50 PRODUCTS OFFERED FOR THE DIAGNOSIS OF OTHER INFECTIONS IN COMPANION ANIMALS
TABLE 51 OTHER INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY REGION, 2019–2026 (USD MILLION)
7.3 FOOD-PRODUCING ANIMALS
7.3.1 INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY ANIMAL TYPE
TABLE 52 POPULATION OF FOOD-PRODUCING ANIMALS IN THE US, 2012 TO 2019 (MILLION)
TABLE 53 INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 54 INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY COUNTRY, 2019–2026 (USD MILLION)
7.3.1.1 Cattle
7.3.1.1.1 Growing demand for meat & dairy products to support the growth of this segment
TABLE 55 SOME OF THE MAJOR ZOONOTIC DISEASES AFFECTING CATTLE
TABLE 56 SOME OF THE MAJOR INFECTIOUS DISEASES AFFECTING CATTLE
TABLE 57 MARKET FOR CATTLE, BY COUNTRY, 2019–2026 (USD MILLION)
7.3.1.2 Swine
7.3.1.2.1 Extensive use of infectious disease diagnostics as a response to epidemic outbreaks in this segment
TABLE 58 SOME OF THE MAJOR ZOONOTIC DISEASES AFFECTING SWINE
TABLE 59 SOME OF THE MAJOR INFECTIOUS DISEASES AFFECTING SWINE
TABLE 60 MARKET FOR SWINE, BY COUNTRY, 2019–2026 (USD MILLION)
7.3.1.3 Poultry
7.3.1.3.1 The growth of this segment is driven by the growing poultry population and rising production volumes
TABLE 61 SOME OF THE IMPORTANT ZOONOTIC DISEASES AFFECTING POULTRY
TABLE 62 SOME IMPORTANT INFECTIOUS DISEASES AFFECTING POULTRY
TABLE 63 MARKET FOR POULTRY, BY COUNTRY, 2019–2026 (USD MILLION)
7.3.1.4 Other food-producing animals
TABLE 64 SOME OF THE MAJOR ZOONOTIC DISEASES AFFECTING OTHER FOOD -PRODUCING ANIMALS
TABLE 65 MARKET FOR OTHER FOOD-PRODUCING ANIMALS, BY COUNTRY, 2019–2026 (USD MILLION)
7.3.2 MARKET FOR FOOD-PRODUCING ANIMALS, BY INFECTION TYPE
TABLE 66 MARKET FOR FOOD-PRODUCING ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)
7.3.2.1 Bacterial infections
7.3.2.1.1 The bacterial infections segment accounted for the largest share of the food-producing animals market in 2020
TABLE 67 PRODUCTS OFFERED FOR THE DIAGNOSIS OF BACTERIAL INFECTIONS IN FOOD-PRODUCING ANIMALS
TABLE 68 BACTERIAL DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY REGION, 2019–2026 (USD MILLION)
7.3.2.2 Viral infections
7.3.2.2.1 Need for early disease diagnosis and the rising awareness for viral infections to support the market growth
TABLE 69 PRODUCTS OFFERED FOR THE DIAGNOSIS OF VIRAL INFECTIONS IN FOOD-PRODUCING ANIMALS
TABLE 70 VIRAL DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY REGION, 2019–2026 (USD MILLION)
7.3.2.3 Parasitic infections
7.3.2.3.1 Worm infestations are a significant problem for pet & companion animal owners
TABLE 71 PRODUCTS OFFERED FOR THE DIAGNOSIS OF PARASITIC INFECTIONS IN FOOD-PRODUCING ANIMALS
TABLE 72 PARASITIC DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY REGION, 2019–2026 (USD MILLION)
7.3.2.4 Other infections
TABLE 73 PRODUCTS OFFERED FOR THE DIAGNOSIS OF FUNGAL INFECTIONS IN FOOD-PRODUCING ANIMALS
TABLE 74 PRODUCTS OFFERED FOR THE DIAGNOSIS OF OTHER INFECTIONS IN FOOD- PRODUCING ANIMALS
TABLE 75 OTHER INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY REGION, 2019–2026 (USD MILLION)
8 VETERINARY INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY END USER (Page No. - 160)
8.1 INTRODUCTION
TABLE 76 VETERINARY INFECTIOUS DISEASES DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
8.2 VETERINARY REFERENCE LABORATORIES
8.2.1 VETERINARY REFERENCE LABORATORIES IS THE LARGEST END USER SEGMENT
TABLE 77 MARKET FOR REFERENCE LABORATORIES, BY COUNTRY, 2019–2026 (USD MILLION)
8.3 VETERINARY HOSPITALS & CLINICS
8.3.1 INCREASED PET OWNERSHIP AND SPENDING ON PET CARE TO PROPEL MARKET GROWTH
FIGURE 33 US: PET INDUSTRY EXPENDITURE
FIGURE 34 ANNUAL ROUTINE VETERINARY VISIT EXPENDITURE: DOGS AND CATS
TABLE 78 MARKET FOR VETERINARY HOSPITALS & CLINICS, BY COUNTRY, 2019–2026 (USD MILLION)
8.4 POINT-OF-CARE/ IN-HOUSE TESTING
8.4.1 POINT-OF-CARE TESTING IS EASY-TO-USE, COST-EFFECTIVE, AND OFFERS SWIFT RESULTS
TABLE 79 KEY PRODUCTS OFFERED BY MARKET PLAYERS
TABLE 80 MARKET FOR POINT-OF-CARE/ IN-HOUSE TESTING, BY COUNTRY, 2019–2026 (USD MILLION)
8.5 VETERINARY RESEARCH INSTITUTES & UNIVERSITIES
8.5.1 INCREASING COLLABORATIONS BETWEEN PRIVATE COMPANIES AND VETERINARY RESEARCH INSTITUTES & UNIVERSITIES TO DRIVE MARKET GROWTH
TABLE 81 MARKET FOR VETERINARY RESEARCH INSTITUTES & UNIVERSITIES, BY COUNTRY, 2019–2026 (USD MILLION)
9 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY REGION (Page No. - 170)
9.1 INTRODUCTION
TABLE 82 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS INDUSTRY, BY REGION, 2019–2026 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 35 EXPECTED GROWTH IN THE NUMBER OF VETERINARIANS IN NORTH AMERICA
FIGURE 36 NORTH AMERICA: MARKET SNAPSHOT
TABLE 83 NORTH AMERICA: MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 84 NORTH AMERICA: MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 85 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 86 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 87 NORTH AMERICA: MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 88 NORTH AMERICA: MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 89 NORTH AMERICA: MARKET FOR COMPANION ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 90 NORTH AMERICA: MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 91 NORTH AMERICA: MARKET FOR FOOD-PRODUCING ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 92 NORTH AMERICA: MARKET, BY END USER, 2019–2026 (USD MILLION)
9.2.1 US
9.2.1.1 The US dominated the North American veterinary infectious disease diagnostics market in 2020
FIGURE 37 US: DOGS POPULATION, 2012–2020 (MILLION)
FIGURE 38 US: EXPENDITURE ON VET VISITS
TABLE 93 US: FOOD-PRODUCING ANIMAL POPULATION, 2001–2019 (MILLION)
FIGURE 39 US: NUMBER OF CATS AND DOGS TESTED POSITIVE FOR COVID-19 (2020)
TABLE 94 US: NUMBER OF VETERINARIANS IN PRIVATE CLINICAL PRACTICES, 2014–2019
TABLE 95 US: MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 96 US: VETERINARY INFECTIOUS DISEASE IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 97 US: VETERINARY INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 98 US: MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 99 US: MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 100 US: MARKET FOR COMPANION ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 101 US: MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 102 US: MARKET FOR FOOD-PRODUCING ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 103 US: MARKET, BY END USER, 2019–2026 (USD MILLION)
9.2.2 CANADA
9.2.2.1 Growing pet adoption in Canada to drive the market growth
FIGURE 40 CANADA: COMPANION ANIMAL POPULATION, 2016–2020 (MILLION)
TABLE 104 CANADA: LARGE ANIMAL POPULATION, 2001–2019 (MILLION)
TABLE 105 CANADA: MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 106 CANADA: VETERINARY INFECTIOUS DISEASE IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 107 CANADA: VETERINARY INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 108 CANADA: MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 109 CANADA: MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 110 CANADA: MARKET FOR COMPANION ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 111 CANADA: MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 112 CANADA: MARKET FOR COMPANION ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 113 CANADA: MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3 EUROPE
TABLE 114 EUROPE: COMPANION POPULATION, 2019 (MILLION)
TABLE 115 EUROPE: LIVESTOCK POPULATION, 2019 (MILLION)
FIGURE 41 EU-27: LIVESTOCK POPULATION, 2012-2019 (MILLION)
TABLE 116 EUROPE: NUMBER OF VETERINARIANS, 2012–2019
TABLE 117 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 118 EUROPE: MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 119 EUROPE: VETERINARY INFECTIOUS DISEASE IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 120 EUROPE: VETERINARY INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 121 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 122 EUROPE: MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 123 EUROPE: MARKET FOR COMPANION ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 124 EUROPE: MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 125 EUROPE: MARKET FOR FOOD-PRODUCING ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 126 EUROPE: MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3.1 GERMANY
9.3.1.1 Rising awareness regarding zoonotic diseases to drive the market growth in Germany
TABLE 127 GERMANY: COMPANION ANIMAL POPULATION, 2016–2019 (MILLION)
TABLE 128 GERMANY: LIVESTOCK ANIMAL POPULATION, 2016–2019 (MILLION)
TABLE 129 GERMANY: NUMBER OF VETERINARIANS, 2014 VS. 2019
TABLE 130 GERMANY: MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 131 GERMANY: VETERINARY INFECTIOUS DISEASE IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 132 GERMANY: VETERINARY INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 133 GERMANY: MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 134 GERMANY: MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 135 GERMANY: MARKET FOR COMPANION ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 136 GERMANY: MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 137 GERMANY: MARKET FOR FOOD-PRODUCING ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 138 GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3.2 UK
9.3.2.1 The UK is the fastest-growing market for veterinary infectious disease diagnostics in Europe
TABLE 139 UK: COMPANION ANIMAL POPULATION (2010–2019) (MILLION)
TABLE 140 UK: LIVESTOCK ANIMAL POPULATION, 2016–2019 (MILLION)
TABLE 141 UK: MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 142 UK: VETERINARY INFECTIOUS DISEASE IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 143 UK: VETERINARY INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 144 UK: MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 145 UK: MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 146 UK: MARKET FOR COMPANION ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 147 UK: MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 148 UK: MARKET FOR FOOD-PRODUCING ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 149 UK: MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3.3 FRANCE
9.3.3.1 France is one of the leading markets for companion pet ownership
TABLE 150 FRANCE: COMPANION ANIMAL POPULATION, 2010–2019 (MILLION)
TABLE 151 FRANCE: LIVESTOCK ANIMAL POPULATION, 2016–2019 (MILLION)
TABLE 152 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 153 FRANCE: VETERINARY INFECTIOUS DISEASE IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 154 FRANCE: VETERINARY INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 155 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 156 FRANCE: MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 157 FRANCE: MARKET FOR COMPANION ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 158 FRANCE: MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 159 FRANCE: MARKET FOR FOOD-PRODUCING ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 160 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3.4 ITALY
9.3.4.1 Rising awareness about pet healthcare to propel the market growth for veterinary diagnostic products in Italy
TABLE 161 ITALY: COMPANION ANIMAL POPULATION, 2012–2019 (MILLION)
TABLE 162 ITALY: MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 163 ITALY: VETERINARY INFECTIOUS IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 164 ITALY: VETERINARY INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 165 ITALY: MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 166 ITALY: MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 167 ITALY: MARKET FOR COMPANION ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 168 ITALY: VETERINARY DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 169 ITALY: MARKET FOR FOOD-PRODUCING ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 170 ITALY: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3.5 SPAIN
9.3.5.1 Growing demand for pig & poultry products to support the adoption of veterinary diagnostic products in Spain
TABLE 171 SPAIN: COMPANION ANIMAL POPULATION, 2016–2019 (MILLION)
TABLE 172 SPAIN: LIVESTOCK ANIMAL POPULATION, 2016–2019 (MILLION)
TABLE 173 SPAIN: MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 174 SPAIN: VETERINARY INFECTIOUS IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 175 SPAIN: VETERINARY INFECTIOUS MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 176 SPAIN: MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 177 SPAIN: MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 178 SPAIN: MARKET FOR COMPANION ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 179 SPAIN: MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 180 SPAIN: MARKET FOR FOOD-PRODUCING ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 181 SPAIN: MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3.6 REST OF EUROPE
TABLE 182 ROE: COMPANION ANIMAL OWNERSHIP, BY COUNTRY, 2019 (MILLION)
TABLE 183 ROE: LIVESTOCK ANIMAL POPULATION, BY COUNTRY, 2019 (MILLION)
TABLE 184 ROE: NUMBER OF VETERINARIANS AND PARAVETERINARIANS, 2010 VS. 2019
TABLE 185 ROE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 186 ROE: VETERINARY INFECTIOUS IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 187 ROE: VETERINARY INFECTIOUS MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 188 ROE: MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 189 ROE: MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 190 ROE: MARKET FOR COMPANION ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 191 ROE: MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 192 ROE: MARKET FOR FOOD-PRODUCING ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 193 ROE: MARKET, BY END USER, 2019–2026 (USD MILLION)
9.4 ASIA PACIFIC
FIGURE 42 ASIA PACIFIC: MARKET SNAPSHOT
TABLE 194 ASIA PACIFIC: MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 195 ASIA PACIFIC: , BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 196 ASIA PACIFIC: VETERINARY INFECTIOUS IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 197 ASIA PACIFIC: VETERINARY INFECTIOUS MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 198 ASIA PACIFIC: MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 199 ASIA PACIFIC: MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 200 ASIA PACIFIC: COMPANION ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 201 ASIA PACIFIC: MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 202 ASIA PACIFIC: FOOD-PRODUCING ANIMALS ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 203 ASIA PACIFIC: MARKET, BY END USER, 2019–2026 (USD MILLION)
9.4.1 CHINA
9.4.1.1 China dominated the APAC veterinary infectious disease diagnostic market in 2020
TABLE 204 CHINA: LIVESTOCK POPULATION, 2010-2019 (MILLION)
TABLE 205 CHINA: MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 206 CHINA: VETERINARY INFECTIOUS DISEASE IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 207 CHINA: VETERINARY INFECTIOUS MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 208 CHINA: MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 209 CHINA: MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 210 CHINA: COMPANION ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 211 CHINA: MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 212 CHINA: FOOD-PRODUCING ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 213 CHINA: MARKET, BY END USER, 2019–2026 (USD MILLION)
9.4.2 JAPAN
9.4.2.1 Rising awareness about zoonotic diseases and increasing pet expenditure to drive market growth
TABLE 214 JAPAN: PRODUCTION, CONSUMPTION, IMPORT, AND EXPORT OF ANIMAL-DERIVED FOOD PRODUCTS, 2000 VS. 2030 (THOUSAND METRIC TONS)
TABLE 215 JAPAN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 216 JAPAN: VETERINARY INFECTIOUS IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 217 JAPAN: VETERINARY INFECTIOUS MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 218 JAPAN: MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 219 JAPAN: MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 220 JAPAN: COMPANION ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 221 JAPAN: MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 222 JAPAN: FOOD-PRODUCING ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 223 JAPAN: MARKET, BY END USER, 2019–2026 (USD MILLION)
9.4.3 INDIA
9.4.3.1 India to become an untapped market with huge growth potential
TABLE 224 INDIA: LIVESTOCK POPULATION, 2007-2019 (MILLION)
TABLE 225 INDIA: PRODUCTION AND CONSUMPTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2000 VS. 2030 (THOUSAND METRIC TONS)
TABLE 226 INDIA: MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 227 INDIA: VETERINARY INFECTIOUS IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 228 INDIA: VETERINARY INFECTIOUS MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 229 INDIA: MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 230 INDIA: MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 231 INDIA: COMPANION ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 232 INDIA: MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 233 INDIA: FOOD- PRODUCING ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 234 INDIA: MARKET, BY END USER, 2019–2026 (USD MILLION)
9.4.4 REST OF APAC
TABLE 235 REST OF APAC: LIVESTOCK POPULATION, BY COUNTRY, 2010-2019 (MILLION)
TABLE 236 ROAPAC: MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 237 ROAPAC: VETERINARY INFECTIOUS IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 238 ROAPAC: VETERINARY INFECTIOUS MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 239 ROAPAC: MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 240 ROAPAC: MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 241 ROAPAC: COMPANION ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 242 ROPAC: MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 243 ROPAC: FOOD-PRODUCING ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 244 ROPAC: MARKET, BY END USER, 2019–2026 (USD MILLION)
9.5 LATIN AMERICA
TABLE 245 LATIN AMERICA: LIVESTOCK POPULATION, BY COUNTRY, 2010-2019 (MILLION)
TABLE 246 LATIN AMERICA: NUMBER OF VETERINARIANS AND PARA VETERINARIANS, 2010 VS. 2019
TABLE 247 LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 248 LATIN AMERICA: MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 249 LATIN AMERICA: VETERINARY INFECTIOUS IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 250 LATIN AMERICA: VETERINARY INFECTIOUS MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 251 LATIN AMERICA: MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 252 LATIN AMERICA: MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 253 LATIN AMERICA: COMPANION ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 254 LATIN AMERICA: MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 255 LATIN AMERICA: FOOD-PRODUICNG ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 256 LATIN AMERICA: MARKET, BY END USER, 2019–2026 (USD MILLION)
9.5.1 BRAZIL
9.5.1.1 Brazil has the fourth-largest pet population in the world
TABLE 257 BRAZIL: MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 258 BRAZIL: VETERINARY INFECTIOUS IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 259 BRAZIL: VETERINARY INFECTIOUS MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 260 BRAZIL: MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 261 BRAZIL: MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 262 BRAZIL: COMPANION ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 263 BRAZIL: MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 264 BRAZIL: FOOD-PRODUCING ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 265 BRAZIL: MARKET, BY END USER, 2019–2026 (USD MILLION)
9.5.2 MEXICO
9.5.2.1 Mexico is the second-largest pet care market in Latin America
TABLE 266 MEXICO: INCREASE IN LIVESTOCK POPULATION, 2010–2019 (MILLION)
TABLE 267 MEXICO: MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 268 MEXICO: VETERINARY INFECTIOUS IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 269 MEXICO: VETERINARY INFECTIOUS MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 270 MEXICO: MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 271 MEXICO: MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 272 MEXICO: COMPANION ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 273 MEXICO: MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 274 MEXICO: FOOD-PRODUCING ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 275 MEXICO: MARKET, BY END USER, 2019–2026 (USD MILLION)
9.5.3 REST OF LATIN AMERICA
TABLE 276 ROLA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 277 ROLA: VETERINARY INFECTIOUS IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 278 ROLA: VETERINARY INFECTIOUS MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 279 ROLA: MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 280 ROLA: MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 281 ROLA: COMPANION ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 282 ROLA: MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 283 ROLA: MARKET FOR FOOD-PRODUCING ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 284 ROLA: MARKET, BY END USER, 2019–2026 (USD MILLION)
9.6 MIDDLE EAST & AFRICA
9.6.1 MIDDLE EAST & AFRICA IS AN EMERGING MARKET FOR VETERINARY INFECTIOUS DISEASE DIAGNOSTICS PRODUCTS
TABLE 285 MIDDLE EAST: LIVESTOCK POPULATION, 2010 VS. 2019 (MILLION)
TABLE 286 MIDDLE EAST: NUMBER OF VETERINARIANS AND PARAVETERINARIANS, 2010 VS. 2018
TABLE 287 AFRICA: FOOD-PRODUCING ANIMAL POPULATION, 2012–2019 (MILLION)
TABLE 288 AFRICA: NUMBER OF VETERINARIANS AND PARA VETERINARIANS, 2010–2018
TABLE 289 MEA: MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 290 MEA: VETERINARY INFECTIOUS IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 291 MEA: VETERINARY INFECTIOUS MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 292 MEA: MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 293 MEA: MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 294 MEA: COMPANION ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 295 MEA: MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 296 MEA: FOOD-PRODUCING ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 297 MEA: MARKET, BY END USER, 2019–2026 (USD MILLION)
10 COMPETITIVE LANDSCAPE (Page No. - 262)
10.1 OVERVIEW
10.2 KEY PLAYER STRATEGIES/ RIGHT TO WIN
10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET
10.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS
FIGURE 43 REVENUE ANALYSIS OF THE TOP PLAYERS IN THE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS INDUSTRY
10.4 MARKET SHARE ANALYSIS
FIGURE 44 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS INDUSTRY SHARE, BY KEY PLAYER, 2020
TABLE 298 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS INDUSTRY: DEGREE OF COMPETITION
10.5 COMPETITIVE LEADERSHIP MAPPING
10.5.1 STARS
10.5.2 EMERGING LEADERS
10.5.3 PERVASIVE PLAYERS
10.5.4 PARTICIPANTS
FIGURE 45 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS INDUSTRY: COMPETITIVE LEADERSHIP MAPPING (2020)
10.6 COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS
10.6.1 PROGRESSIVE COMPANIES
10.6.2 DYNAMIC COMPANIES
10.6.3 STARTING BLOCKS
10.6.4 RESPONSIVE COMPANIES
FIGURE 46 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS INDUSTRY: COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS (2020)
10.7 COMPANY FOOTPRINT
TABLE 299 COMPANY FOOTPRINT: MARKET
10.7.1 TECHNOLOGY FOOTPRINT OF MAJOR PLAYERS IN THE MARKET
TABLE 300 TECHNOLOGY FOOTPRINT: MARKET (2020)
10.7.2 ANIMAL FOOTPRINT OF MAJOR PLAYERS IN THE MARKET
TABLE 301 ANIMAL TYPE FOOTPRINT: MARKET (2020)
10.7.3 END-USER FOOTPRINT OF MAJOR PLAYERS IN THE MARKET
TABLE 302 END-USER FOOTPRINT: MARKET (2020)
10.7.4 GEOGRAPHIC FOOTPRINT OF MAJOR PLAYERS IN THE MARKET
TABLE 303 GEOGRAPHIC FOOTPRINT: MARKET (2020)
10.8 COMPETITIVE SCENARIO
10.8.1 PRODUCT LAUNCHES
TABLE 304 PRODUCT LAUNCHES, 2018–2021
10.8.2 DEALS
TABLE 305 DEALS, 2018–2021
10.8.3 OTHER DEVELOPMENTS
TABLE 306 OTHER DEVELOPMENTS, 2018–2021
11 COMPANY PROFILES (Page No. - 279)
11.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1.1 IDEXX LABORATORIES, INC.
TABLE 307 IDEXX LABORATORIES, INC.: BUSINESS OVERVIEW
FIGURE 47 IDEXX LABORATORIES, INC.: COMPANY SNAPSHOT (2020)
11.1.2 ZEOTIS
TABLE 308 ZOETIS: BUSINESS OVERVIEW
FIGURE 48 ZOETIS: COMPANY SNAPSHOT (2020)
11.1.3 THERMO FISHER SCIENTIFIC INC.
TABLE 309 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW
FIGURE 49 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2020)
11.1.4 VIRBAC
TABLE 310 VIRBAC: BUSINESS OVERVIEW
FIGURE 50 VIRBAC: COMPANY SNAPSHOT (2020)
11.1.5 BIOMERIEUX S.A.
TABLE 311 BIOMERIEUX S.A.: BUSINESS OVERVIEW
FIGURE 51 BIOMERIEUX S.A.: COMPANY SNAPSHOT (2020)
11.1.6 HESKA CORPORATION
TABLE 312 HESKA CORPORATION: BUSINESS OVERVIEW
FIGURE 52 HESKA CORPORATION: COMPANY SNAPSHOT (2020)
11.1.7 IDVET
TABLE 313 IDVET: BUSINESS OVERVIEW
11.1.8 NEOGEN CORPORATION
TABLE 314 NEOGEN CORPORATION: BUSINESS OVERVIEW
FIGURE 53 NEOGEN CORPORATION: COMPANY SNAPSHOT (2020)
11.1.9 QIAGEN N.V. (A PART OF INDICAL BIOSCIENCE)
TABLE 315 QIAGEN N.V.: BUSINESS OVERVIEW
FIGURE 54 QIAGEN N.V.: COMPANY SNAPSHOT (2020)
11.1.10 RANDOX LABORATORIES LTD.
TABLE 316 RANDOX LABORATORIES LTD.: BUSINESS OVERVIEW
11.1.11 AGROLABO S.P.A.
TABLE 317 AGROLABO S.P.A.: BUSINESS OVERVIEW
11.1.12 BIONOTE USA INC.
TABLE 318 BIONOTE USA INC.: BUSINESS OVERVIEW
11.1.13 BIOGAL GALED LABS
TABLE 319 BIOGAL GALED LABS: BUSINESS OVERVIEW
11.1.14 BIOCHEK
TABLE 320 BIOCHEK: BUSINESS OVERVIEW
11.1.15 BIOPANDA REAGENTS LTD.
TABLE 321 BIOPANDA REAGENTS LTD.: BUSINESS OVERVIEW
11.1.16 URIT MEDICAL ELECTRONIC CO., LTD.
TABLE 322 URIT MEDICAL ELECTRONIC CO., LTD.: BUSINESS OVERVIEW
11.1.17 MEGACOR DIAGNOSTIK GMBH
TABLE 323 MEGACOR DIAGNOSTIK GMBH: BUSINESS OVERVIEW
11.1.18 BIO-RAD LABORATORIES, INC.
TABLE 324 BIO-RAD LABORATORIES: BUSINESS OVERVIEW
FIGURE 55 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2020)
11.1.19 LIVET
TABLE 325 LIVET: BUSINESS OVERVIEW
11.1.20 INDICAL BIOSCIENCE GMBH
TABLE 326 INDICAL BIOSCIENCE GMBH: BUSINESS OVERVIEW
11.2 OTHER PLAYERS
11.2.1 FASSISI, GMBH
11.2.2 ALVEDIA
11.2.3 SKYER, INC.
11.2.4 SHENZHEN BIOEASY BIOTECHNOLOGY CO., LTD.
11.2.5 PRECISION BIOSENSOR
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
12 APPENDIX (Page No. - 382)
12.1 INSIGHTS FROM INDUSTRY EXPERTS
12.2 DISCUSSION GUIDE
12.3 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.4 AVAILABLE CUSTOMIZATIONS
12.5 RELATED REPORTS
12.6 AUTHOR DETAILS
The report presents a detailed assessment of the veterinary infectious disease diagnostics market, along with qualitative inputs and insights from MarketsandMarkets. This research study involved the extensive use of both primary and secondary sources. Various factors affecting the industry were studied to identify the segmentation types, industry trends, key players, competitive landscape of different products and services provided by market players, key player strategies, and key market dynamics, such as drivers, restraints, opportunities, challenges, and industry trends.
Secondary Research
This research study involved the use of comprehensive secondary sources; directories; databases such as Bloomberg Business, Factiva, and Dun & Bradstreet; white papers; annual reports; companies’ house documents; investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the patient handling equipment market. It was also used to obtain important information about the key players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.
Primary Research
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include CEOs, vice presidents, managing directors, marketing heads and sales directors, marketing managers, product managers and related key executives from various key companies and organizations operating in the Veterinary Infectious Disease Diagnostic Market. The primary sources from the demand side include hospital managers, directors, healthcare providers, department heads, research and academic professionals.
A breakdown of the primary respondents is provided below:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The total size of the veterinary infectious disease diagnostics market was arrived at after data triangulation from three different approaches- demand side modelling, revenue share analysis and primary interviews. After the completion of each approach, the weighted average of the three approaches was taken based on the level of assumptions used in each approach.
Data Triangulation
After arriving at the market size, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed wherever applicable.
Objectives of the Study
- To define, describe, segment, and forecast the veterinary infectious disease diagnostics market by technology, animal type, end user, and region
- To provide detailed information about the factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
- To analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall veterinary infectious disease diagnostics market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the veterinary infectious disease diagnostics market in five main regions (along with their respective key countries), namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
- To profile the key players in the veterinary infectious disease diagnostics market and comprehensively analyze their core competencies2 and market shares
- To track and analyze the competitive developments such as acquisitions, product launches, expansions, collaborations, agreements, partnerships, and R&D activities of the leading players in the veterinary infectious disease diagnostics market
- To benchmark players within the veterinary infectious disease diagnostics market using the competitive leadership mapping framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offering
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:
Geographic Analysis
- Further breakdown of the Rest of Europe veterinary infectious disease diagnostics market into Switzerland, the Netherlands, Belgium, and others.
- Further breakdown of the Middle East & Africa veterinary infectious disease diagnostics market into Saudi Arabia, the UAE, and others.
Portfolio Assessment
- Product matrix, which gives a detailed comparison of the product portfolio of each company
Generating Response ...
Growth opportunities and latent adjacency in Veterinary Infectious Disease Diagnostics Market
Which factors are fueling the growth of Asia Pacific region in the global Veterinary Infectious Disease Diagnostics Market?
Under the technology segment, which sub-segment is expected to gain the largest share of the global Veterinary Infectious Disease Diagnostics Market?
Can you please share some more light on the key players and different growth strategies adopted by them in the global Veterinary Infectious Disease Diagnostics Market?